withdraw my consent at any time during treatment or follow-up with no loss of benefits or disruption in 
my care. 
POTENTIAL BENEFITS FOR PARTICIPANTS 
I understand that there may be no direct benefit to me from study participation, and there is a 
possibility my condition may become worse. In the past, lymphocyte and IL-2 infusions have resulted in 
some tumor shrinkage in some individuals but not in others. Even those tumors that exhibit shrinkage 
may show regrowth after a short period of time. A better understanding of immunity to cancer may be 
gained by my participation that would benefit other patients. 
ALTERNATIVE THERAPIES 
There are no known cures for patients with my disease. I am aware that alternative treatments 
available to me include chemotherapy or other experimental treatments. The option also exists to receive 
no treatment at this time. 
OTHER PERTINENT INFORMATION 
1 . Confidentiality. I understand that when results of a study such as this are reported to medical 
journals or at meetings, the identification of those taking part is withheld. Medical records are 
maintained according to current legal requirements, and are made available for review, as required 
by the Food and Drug Administration or other authorized users, only under the guidelines 
established by the Federal Privacy Act. A qualified representative of the National Institutes of 
Health may inspect patient and study records. I understand that this experimental treatment may 
attract attention from the media. I have been informed that every effort to protect my confidentiality 
will be made. Because of media interest, however, I realize there is a significant chance that 
information concerning me and my treatment may appear publicly without my consent. 
2. Policy regarding research-related injuries. I understand that in the unlikely event a physical injury 
resulting from research procedures, the University will provide first-aid medical treatment. 
Treatment of injuries or side effects directly related to this experimental treatment will be provided 
at no cost to me. Additional medical treatment will be provided in accordance with the 
determination by the University of responsibility to provide such treatment. However, the 
University does not provide compensation to a person who is injured while participating as a 
subject in research. 
3 . I will not be paid to take part in this study. 
4. Laboratory tests and scans will be ordered to determine my eligibility for study and whether I have 
had a response to the treatment. Items which are not covered by insurance which relate to this 
research protocol will be free. The cost of tests and treatments unrelated to this study will be 
charged for. I understand that insurance coverage cannot be guaranteed for all tests and treatments. 
5 . This consent form does not include consent relating to the risks of any surgical procedures. Any 
surgical procedures performed will require a separate consent form. 
6. This research may have unforeseeable risks to an embryo or fetus. If I could potentially father a 
child or bear a child; I will not participate in this research study unless I am employing a medically 
acceptable form of birth control (contraception). 
7 . Iam free to withdraw my consent to participate in this study at any time during treatment or follow- 
up and seek care from any physician with no loss of benefits or disruption in my care. 
If you have questions pertinent to this research, you should contact Alfred E. Chang, M.D., at 
313/936-4392. 
Recombinant DNA Research, Volume 18 
[809] 
